A new study in the Journal Pediatrics finds infants born at 37 or 38 weeks, who are technically "at term," have an increased risk of developmental delays or other medical difficulties. Researchers analyzed data from 128 thousand babies in New York City and matched their birth records with their 3rd Grade math and reading tests. They found achievement scores for children born at 37 and 38 weeks were significantly lower than those of children born at 39, 40 and 41 weeks. Scientists say the infant brain grows rapidly in the last weeks of gestation.
Also, drug maker GlaxoSmithKline has agreed to pay a whopping three billion dollars to settle criminal and civil claims over some of its medications. It's the largest fraud settlement in US history and the largest payment ever by a drug company. The Justice Department had accused the company of marketing some of its drugs as treatments for conditions they weren't approved for. It also accused GlaxoSmithKline of failing to report safety information concerning its diabetes medication, Avandia. In a statement, the company's CEO Andrew Witty said the company regrets what happened and has learned from the mistakes it made.